Related Experiment Video
Updated: Jun 18, 2026
07:47
Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction
Published on: September 26, 2020
Preview. Mending the failing heart with a vascularized cardiac patch
Donny Hanjaya-Putra1, Sharon Gerecht
1Department of Chemical and Biomolecular Engineering, Johns Hopkins Physical Science Oncology Center and Institute for NanoBio Technology, Johns Hopkins University, Baltimore, MD 21218, USA.
Cell Stem Cell
|December 3, 2009
Summary
Researchers successfully integrated vascular cells and human embryonic stem cell-derived cardiomyocytes into stable cardiac grafts. This advancement is crucial for developing vascularized myocardial constructs for tissue engineering and regenerative medicine applications.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Cardiovascular Research
Background:
- Functional cardiac grafts require vascularization for survival and integration.
- Host vasculature integration is a key challenge in myocardial tissue engineering.
- Human embryonic stem cell-derived cardiomyocytes offer potential for cardiac repair.
Purpose of the Study:
- To investigate the integration of vascular cells and human embryonic stem cell-derived cardiomyocytes into stable cardiac grafts.
- To assess the survival and vascular integration of engineered cardiac constructs in vivo.
- To establish a foundation for developing vascularized myocardial tissue for transplantation.
Main Methods:
- Co-culture of vascular cells with human embryonic stem cell-derived cardiomyocytes.
- Fabrication of myocardial constructs.
- Grafting of constructs into rat recipients.
- Assessment of graft survival and vascularization using histological and imaging techniques.
Main Results:
- Successful integration of vascular cells and human embryonic stem cell-derived cardiomyocytes into stable grafts.
- Demonstrated survival of the engineered cardiac constructs within the host environment.
- Evidence of integration with the host vasculature.
Conclusions:
- Engineered cardiac grafts composed of vascular cells and human embryonic stem cell-derived cardiomyocytes can achieve stable integration and vascularization.
- This study provides a promising strategy for creating vascularized myocardial constructs for cardiac regenerative medicine.
- Further research can build upon these findings for clinical applications in treating heart disease.
